Investigation on release of highly water soluble drug from matrix-coated pellets prepared by extrusion–spheronization technique

被引:0
作者
Muhammad Iqbal Nasiri
Rabia Ismail Yousuf
Muhammad Harris Shoaib
Muhammad Fayyaz
Faaiza Qazi
Kamran Ahmed
机构
[1] University of Karachi,Department of Pharmaceutics, Faculty of Pharmacy
来源
Journal of Coatings Technology and Research | 2016年 / 13卷
关键词
Itopride hydrochloride; Pellets; Ethyl cellulose; Extended release; Extrusion–spheronization;
D O I
暂无
中图分类号
学科分类号
摘要
The objective was to formulate itopride HCl (ITP) extended release matrix-coated pellets by extrusion–spheronization and to investigate the influence of concentration and viscosity grade of different polymers on release of a highly water soluble drug. The matrix pellet formulations consisted of polymers (10–30%) like hydroxypropyl methylcellulose (HPMC K4M, K15M, and K100M), ethyl cellulose (EC-7 cps), microcrystalline cellulose (10–30%) and a fixed quantity of lactose (10%). The initial fast drug release from the matrix pellets was effectively controlled by coating with 5% ethyl cellulose (10 cps) dispersion. The dissolution studies of coated formulations were carried out at different pH, and data were analyzed for drug release kinetics. Scanning electron microscope was used to examine the surface morphology and cross section of pellets. Kinetics of all coated formulations were best explained by Higuchi model (R2 = 0.94–0.99). However, HPMC matrix-coated pellets (F1, F4 and F7) also followed Baker and Lonsdale model (R2 = 0.96–0.99), whereas, EC matrix-coated pellets (F10) followed zero-order kinetics (R2 = 0.99). Release mechanism of all coated formulations was non-fickian. Both uncoated and coated pellets were found to be spherical. Fourier transform infrared spectroscopy was conducted on the coated formulations and no drug–excipients interaction was found.
引用
收藏
页码:333 / 344
页数:11
相关论文
共 112 条
[1]  
Wilson B(2011)Design and Evaluation of Sustained Release Matrix Tablets of Levofloxacin for Effective Treatment of Microbial Infections Int. J. Drug Deliv. 3 305-314
[2]  
Sitarambhai PH(1999)Extrusion and Spheronization in the Development of Oral Controlled-Release Dosage Forms Pharm. Sci. Technol. Today 2 160-170
[3]  
Sajeev M(2002)Production of Spherical Pellets by a Hot-Melt Extrusion and Spheronization Process Int. J. Pharm. 242 87-92
[4]  
Vinothapooshan G(1993)Development and In Vitro Evaluation of a Multiparticulate Sustained Release Theophylline Formulation Drug Dev. Ind. Pharm. 19 855-874
[5]  
Gandhi R(2004)Itopride: A Novel Prokinetic Agent JK Sci. 6 106-108
[6]  
Lal Kaul C(2010)Design and In Vitro Evaluation of Extended Release Matrix Tablets of Itopride Hydrochloride Der Pharm. Lett. 2 186-196
[7]  
Panchagnula R(2013)Formulation Development and Evaluation of Diltiazem HCl Sustained Release Matrix Tablets Using HPMC K4M and K100M Pak. J. Pharm. Sci. 26 653-663
[8]  
Young CR(2007)Immediate Release of Poorly Soluble Drugs from Starch-Based Pellets Prepared via Extrusion/Spheronisation Eur. J. Pharm. Biopharm. 67 715-724
[9]  
Koleng JJ(2011)Preparation and Evaluation of Pellets Using Acacia and Tragacanth by Extrusion–Spheronization DARU Journal of Pharmaceutical Sciences 19 417-423
[10]  
McGinity JW(2011)Formulation and Evaluation of Olanzapine Matrix Pellets for Controlled Release DARU Journal of Pharmaceutical Sciences 19 249-256